Skip to main content

Advertisement

SpringerLink
Log in

Atherosclerotic cardiovascular disease: a review of initiators and protective factors

  • Review
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Atherosclerotic cardiovascular disease (CVD) is a collective term comprising of a group of disorders of the heart and blood vessels. These diseases are the largest cause of morbidity and premature death worldwide. Coronary heart disease and cerebrovascular disease (stroke) are the most frequently occurring diseases. The two major initiators involved in the development of atherosclerotic CVD are vascular production of reactive oxygen species (ROS) and lipid oxidation. In atherosclerosis development, ROS is associated with rapid loss of anti-inflammatory and anti-atherogenic activities of the endothelium-derived nitric oxide (NO·) resulting in endothelial dysfunction. In part involving activation of the transcription factor NF-κB, ROS have been involved in signaling cascades leading to vascular pro-inflammatory and pro-thrombotic gene expression. ROS is also a potent activator of matrix metalloproteinases (MMPs), which indicate plaque destabilization and rupture. The second initiator involved in atherosclerotic CVD is the oxidation of low-density lipoproteins (LDL). Oxidation of LDL in vessel wall leads to an inflammatory cascade that activates atherogenic pathway leading to foam cell formation. The accumulation of foam cells leads to fatty streak formation, which is the earliest visible atherosclerotic lesion. In contrast, the cardiac sarco/endoplasmic reticulum Ca2+-ATPase (SERCA2a) and hepatic apolipoprotein E (apoE) expression can improve cardiovascular function. SERCA2a regulates the cardiac contractile function by lowering cytoplasmic calcium levels during relaxation, and affecting NO· action in vascular cells, while apoE is a critical ligand in the plasma clearance of triglyceride- and cholesterol-rich lipoproteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Agha A, Schlüter H, König S, Biel K, Tepel M, Zidek W (1992) A novel platelet-derived renal vasoconstrictor agent in normotensives and essential hypertensives. J Vasc Res 29(3):281–289

    Article  CAS  PubMed  Google Scholar 

  • Arai M, Matsui H, Periasamy M (1994) Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74(4):555–564

    Article  CAS  PubMed  Google Scholar 

  • Baker AH, Edwards DR, Murphy G (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115(Pt 19):3719–3727

    Article  CAS  PubMed  Google Scholar 

  • Borén J, Olin K, Lee I, Chait A, Wight TN, Innerarity TL (1998) Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J Clin Invest 101(12):2658–2664

    Article  PubMed Central  PubMed  Google Scholar 

  • Bourassa MG, Tardif JC (eds) (2006) Antioxidants and cardiovascular disease, 2nd edn. Springer Science & Business Media. ISBN: 978-0387-29552-7

  • Camejo G, Fager G, Rosengren B, Hurt-Camejo E, Bondjers G (1993) Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem 268(19):14131–14137

    CAS  PubMed  Google Scholar 

  • Collins T, Cybulsky MI (2001) NF-κB: pivotal mediator or innocent bystander in atherogenesis? J Clin Invest 107(3):255–264

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M et al (2001) A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107(10):1255–1262

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA, Harding SE (1995) Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92(9):2540–2549

    Article  CAS  PubMed  Google Scholar 

  • Ferrari P, Micheletti R, Valentini G, Bianchi G (2007) Targeting SERCA2a as an innovative approach to the therapy of congestive heart failure. Med Hypotheses 68(5):1120–1125

    Article  CAS  PubMed  Google Scholar 

  • Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408(6809):239–247

    Article  CAS  PubMed  Google Scholar 

  • Flood C, Gustafsson M, Richardson PE, Harvey SC, Segrest JP, Borén J (2002) Identification of the proteoglycan binding site in apolipoprotein B48. J Biol Chem 277(35):32228–32233

    Article  CAS  PubMed  Google Scholar 

  • Galis ZS, Sukhova GK, Lark MW, Libby P (1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94(6):2493–2503

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gotto AM Jr, Farmer JA (1988) Risk factors for coronary artery disease. In: Braunwald E (ed) Heart disease: a textbook of cardiovascular medicine. Saunders, Philadelphia, pp 1153–1190

    Google Scholar 

  • Gotto AM Jr, Grundy SM (1999) Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial data. Issues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting. Circulation 99:E1–E7

    Article  PubMed  Google Scholar 

  • Grote K, Flach I, Luchtefeld M, Akin E, Holland SM, Drexler H et al (2003) Mechanical stretch enhances mRNA expression and proenzyme release of matrix metalloproteinase-2 (MMP-2) via NAD (P) H oxidase–derived reactive oxygen species. Circ Res 92(11):e80–e86

    Article  CAS  PubMed  Google Scholar 

  • Hakim J (1993) Reactive oxygen species and inflammation. C R Seances Soc Biol Fil 187(3):286–295

    CAS  PubMed  Google Scholar 

  • Hasenfuss G, Reinecke H, Studer R, Meyer M, Pieske B, Holtz J et al (1994) Relation between myocardial function and expression of sarcoplasmic reticulum Ca2+-ATPase in failing and nonfailing human myocardium. Circ Res 75(3):434–442

    Article  CAS  PubMed  Google Scholar 

  • Higashi Y, Noma K, Yoshizumi M, Kihara Y (2009) Endothelial function and oxidative stress in cardiovascular diseases. Circ J 73(3):411–418

    Article  CAS  PubMed  Google Scholar 

  • Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M et al (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88(2):e14–e22

    Article  CAS  PubMed  Google Scholar 

  • Krötz F, Sohn HY, Gloe T, Zahler S, Riexinger T, Schiele TM et al (2002) NAD(P)H-oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 100:917–924

    Article  PubMed  Google Scholar 

  • Krötz F, Sohn HY, Pohl U (2004) Reactive oxygen species players in the platelet game. Arterioscler Thromb Vasc Biol 24(11):1988–1996

    Article  PubMed  Google Scholar 

  • Kuipers F, Jong MC, Lin Y, Eck MV, Havinga R, Bloks V et al (1997) Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes. J Clin Invest 100(11):2915–2922

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Lakshmi SV, Padmaja G, Kuppusamy P, Kutala VK (2009) Oxidative stress in cardiovascular disease. Indian J Biochem Biophys 46:421–440

    CAS  PubMed  Google Scholar 

  • Libby P (2012) Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32(9):2045–2051. doi:10.1161/ATVBAHA.108.179705

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105(9):1135–1143

    Article  CAS  PubMed  Google Scholar 

  • Loscalzo J (2003) Oxidant stress: a key determinant of atherothrombosis. Biochem Soc Trans 31(Pt 5):1059–1061

    Article  CAS  PubMed  Google Scholar 

  • Lüscher TF (1990) Imbalance of endothelium-derived relaxing and contracting factors a new concept in hypertension? Am J Hypertens 3(4):317–330

    Article  PubMed  Google Scholar 

  • Mahley RW, Huang Y (1999) Apolipoprotein E: from atherosclerosis to Alzheimer’s disease and beyond. Curr Opin Lipidol 10(3):207–217

    Article  CAS  PubMed  Google Scholar 

  • Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1(1):507–537

    Article  CAS  PubMed  Google Scholar 

  • Mahley RW, Weisgraber KH, Huang Y (2009) Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer’s disease to AIDS. J Lipid Res 50(Suppl):S183–S188. doi:10.1194/jlr.R800069-JLR200

  • Massova I, Kotra LP, Fridman R, Mobashery S (1998) Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 12(12):1075–1095

    CAS  PubMed  Google Scholar 

  • Maugeais C, Tietge UJ, Tsukamoto K, Glick JM, Rader DJ (2000) Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice. J Lipid Res 41(10):1673–1679

    CAS  PubMed  Google Scholar 

  • Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y et al (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers—smoking as a cause of oxidative damage. N Engl J Med 332(18):1198–1203

    Article  CAS  PubMed  Google Scholar 

  • Nakayama H, Otsu K, Yamaguchi O, Nishida K, Date MO, Hongo K et al (2003) Cardiac-specific overexpression of a high Ca2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy. FASEB J 17(1):61–63

    CAS  PubMed  Google Scholar 

  • Nievelstein PF, Fogelman AM, Mottino G, Frank JS (1991) Lipid accumulation in rabbit aortic intima 2 hours after bolus infusion of low density lipoprotein. A deep-etch and immunolocalization study of ultrarapidly frozen tissue. Arterioscler Thromb 11(6):1795–1805

    Article  CAS  PubMed  Google Scholar 

  • Patruno A, Pesce M, Marrone A, Speranza L, Grilli A, De Lutiis MA et al (2012) Activity of matrix metallo proteinases (MMPs) and the tissue inhibitor of MMP (TIMP)-1 in electromagnetic field-exposed THP-1 cells. J Cell Physiol 227(6):2767–2774. doi:10.1002/jcp.23024

    Article  CAS  PubMed  Google Scholar 

  • Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M et al (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33(13):1635–1701. doi:10.1093/eurheartj/ehs092

    Article  CAS  PubMed  Google Scholar 

  • Pratico D, Pasin M, Barry OP, Ghiselli A, Sabatino G, Iuliano L et al (1999) Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. Circulation 99:3118–3124

    Article  CAS  PubMed  Google Scholar 

  • Proctor SD, Vine DF, Mamo JC (2002) Arterial retention of apolipoprotein B48-and B100-containing lipoproteins in atherogenesis. Curr Opin Lipidol 13(5):461–470

    Article  CAS  PubMed  Google Scholar 

  • Qian H, Neplioueva V, Shetty GA, Channon KM, George SE (1999) Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation 99(23):2979–2982

    Article  CAS  PubMed  Google Scholar 

  • Radomski MW, Palmer RM, Moncada S (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2:1057–1105

    Article  CAS  PubMed  Google Scholar 

  • Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 98(11):2572–2579

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Rao GN, Berk BC (1992) Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70(3):593–599

    Article  CAS  PubMed  Google Scholar 

  • Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J et al (2004) Urinary 8-iso-prostaglandin F2α as a risk marker in patients with coronary heart disease a matched case-control study. Circulation 109(7):843–848

    Article  CAS  PubMed  Google Scholar 

  • Simionescu M, Simionescu N (1993) Proatherosclerotic events: pathobiochemical changes occurring in the arterial wall before monocyte migration. FASEB J 7(14):1359–1366

    CAS  PubMed  Google Scholar 

  • Sorescu D, Weiss D, Lassègue B, Clempus RE, Szöcs K, Sorescu GP et al (2002) Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105(12):1429–1435

    Article  CAS  PubMed  Google Scholar 

  • Sottero B, Gargiulo S, Russo I, Barale C, Poli G, Cavalot F (2015) Postprandial dysmetabolism and oxidative stress in type 2 diabetes: pathogenetic mechanisms and therapeutic strategies. Med Res Rev 35(5):968–1031. doi:10.1002/med.21349

    Article  CAS  PubMed  Google Scholar 

  • Steinberg D (2002) Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat Med 8(11):1211–1217

    Article  CAS  PubMed  Google Scholar 

  • Steinbrecher U, Parthasarathy S, Leake DS, Witztum JL, Steinberg D (1984) Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci 81(12):3883–3887

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Stocker R, Keaney JF (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84(4):1381–1478

    Article  CAS  PubMed  Google Scholar 

  • Sugamura K, Keaney JF (2011) Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51(5):978–992. doi:10.1016/j.freeradbiomed.2011.05.004

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Taleb A, Witztum JL, Tsimikas S (2011) Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events. Biomark Med 5(5):673–694. doi:10.2217/bmm.11.60

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Tong X, Evangelista A, Cohen RA (2010) Targeting the redox regulation of SERCA in vascular physiology and disease. Curr Opin Pharmacol 10(2):133–138. doi:10.1016/j.coph.2009.11.008

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Trogdon JG, Finkelstein EA, Nwaise IA, Tangka FK, Orenstein D (2007) The economic burden of chronic cardiovascular disease for major insurers. Health Promot Pract 8(3):234–242

    Article  PubMed  Google Scholar 

  • Turpaev KT (2002) Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc) 67(3):281–292

    Article  CAS  Google Scholar 

  • Véniant MM, Pierotti V, Newland D, Cham CM, Sanan DA, Walzem RL et al (1997) Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. J Clin Invest 100(1):180–188

    Article  PubMed Central  PubMed  Google Scholar 

  • Watanabe N, Ikeda U (2004) Matrix metalloproteinases and atherosclerosis. Curr Atheroscler Rep 6(2):112–120

    Article  PubMed  Google Scholar 

  • Zalba G, San José G, Moreno MU, Fortuño MA, Fortuño A, Beaumont FJ et al (2001) Oxidative stress in arterial hypertension role of NAD(P)H oxidase. Hypertension 38(6):1395–1399

    Article  CAS  PubMed  Google Scholar 

  • Zheng JS, Yang XQ, Lookingland KJ, Fink GD, Hesslinger C, Kapatos G et al (2003) Gene transfer of human guanosine 5′-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension. Circulation 108(10):1238–1245

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nutrition and Dietetics, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), 43400, Serdang, Malaysia

    Mohammed S. Ellulu, Asmah Rahmat & Faisal Ali

  2. Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), 43400, Serdang, Malaysia

    Ismail Patimah & Huzwah Khaza’ai

  3. Faculty of Public Health, Al Quds University of Gaza, Gaza, Palestine

    Yehia Abed

Authors
  1. Mohammed S. Ellulu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ismail Patimah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huzwah Khaza’ai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Asmah Rahmat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yehia Abed
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Faisal Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammed S. Ellulu.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest with respect to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ellulu, M.S., Patimah, I., Khaza’ai, H. et al. Atherosclerotic cardiovascular disease: a review of initiators and protective factors. Inflammopharmacol 24, 1–10 (2016). https://doi.org/10.1007/s10787-015-0255-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-015-0255-y

Keywords

Search

Navigation